Manufacturer of Controlled Substances; Notice of Application, 30418-30419 [E8-11633]

Download as PDF 30418 Federal Register / Vol. 73, No. 102 / Tuesday, May 27, 2008 / Notices your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Dated: May 20, 2008. Gary D. Cooper, District Manager. [FR Doc. E8–11722 Filed 5–23–08; 8:45 am] BILLING CODE 4310–GG–P DEPARTMENT OF THE INTERIOR Minerals Management Service Extension of Post-Sale Evaluation Period for Central Gulf of Mexico Lease Sale 206 Minerals Management Service (MMS), Interior. ACTION: Notice to Extend Post-Sale Evaluation Period for Central Gulf of Mexico Lease Sale 206. AGENCY: SUMMARY: This notice extends by 30 days, the post-sale evaluation period for Central Gulf of Mexico Lease Sale 206. The Minerals Management Service (MMS) will complete evaluating all the bids received in this sale by July 17, 2008. This action is necessary due to the unusually high number of bids received in this lease sale. DATES: The post-sale evaluation period ends on June 17, 2008. FOR FURTHER INFORMATION CONTACT: David Marin, Regional Supervisor, Resource Evaluation, Gulf of Mexico Region, telephone 504–736–2710. SUPPLEMENTARY INFORMATION: In the Central Gulf of Mexico Sale 206, held March 19, 2008, we received 1057 bids on 615 tracts, 513 tracts of which passed to a second phase requiring additional detailed evaluations. The aggressive bidding activity is due, in part, to the high number of quality prospects on recently expired unexplored tracts in newly established deepwater hydrocarbon plays and to the cost saving technological advances related to hydrocarbon exploration and development in the Gulf of Mexico’s deepwater environment. The unusually high number of bids received on a large number of tracts, and the high volume of exclusively reprocessed data identified on Sale 206, significantly increases the workload for reviewing the adequacy of bids. Consequently, MMS is unable to conduct and complete the bid review process within the 90 days, i.e., by June 17, 2008. Under the provisions of § 256.47(e)(2), MMS is extending the bid evaluation period until July 17, 2008. Dated: May 5, 2008. Lars Herbst, Regional Director, Gulf of Mexico OCS Region. [FR Doc. E8–11711 Filed 5–23–08; 8:45 am] substance intermediates for sale to its customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 28, 2008. BILLING CODE 4310–MR–P Dated: May 15, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–11631 Filed 5–23–08; 8:45 am] DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 25, 2008, Siegfried (USA), Inc., Industrial Park Road, Pennsville, New Jersey 08070, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Oripavine(9330), a basic class of controlled substance listed in schedule II. The company will use the above listed controlled substance in the manufacture of other controlled Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 21, 2007, AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule pwalker on PROD1PC71 with NOTICES Marihuana (7360) ...................................................................................................................................................... Tetrahydrocannabinols (7370) ................................................................................................................................... Amphetamine (1100) ................................................................................................................................................. Lisdexamfetamine (1205) .......................................................................................................................................... Methylphenidate (1724) ............................................................................................................................................. Pentobarbital (2270) .................................................................................................................................................. Hydrocodone (9193) .................................................................................................................................................. Meperidine (9230) ...................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage form) (9273) .............................................................................................. Oxymorphone (9652) ................................................................................................................................................. Fentanyl (9801) .......................................................................................................................................................... The company plans to manufacture bulk controlled substances for use in product development and for VerDate Aug<31>2005 17:22 May 23, 2008 Jkt 214001 distribution to its customers. In reference to drug code 7360 (Marihuana), the company plans to bulk PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 I I II II II II II II II II II manufacture cannabidiol as a synthetic intermediate. This controlled substance will be further synthesized to bulk E:\FR\FM\27MYN1.SGM 27MYN1 Federal Register / Vol. 73, No. 102 / Tuesday, May 27, 2008 / Notices manufacture a synthetic THC (7370). No other activity for this drug code is authorized for this registration. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 28, 2008. Dated: May 19, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–11633 Filed 5–23–08; 8:45 am] BILLING CODE 4410–09–P NATIONAL ARCHIVES AND RECORDS ADMINISTRATION Records Schedules; Availability and Request for Comments National Archives and Records Administration (NARA). ACTION: Notice of availability of proposed records schedules; request for comments. pwalker on PROD1PC71 with NOTICES AGENCY: SUMMARY: The National Archives and Records Administration (NARA) publishes notice at least once monthly of certain Federal agency requests for records disposition authority (records schedules). Once approved by NARA, records schedules provide mandatory instructions on what happens to records when no longer needed for current Government business. They authorize the preservation of records of continuing value in the National Archives of the United States and the destruction, after a specified period, of records lacking administrative, legal, research, or other value. Notice is published for records schedules in which agencies propose to destroy records not previously authorized for disposal or reduce the retention period of records already authorized for disposal. NARA invites public comments on such records schedules, as required by 44 U.S.C. 3303a(a). VerDate Aug<31>2005 17:22 May 23, 2008 Jkt 214001 Requests for copies must be received in writing on or before June 26, 2008. Once the appraisal of the records is completed, NARA will send a copy of the schedule. NARA staff usually prepare appraisal memorandums that contain additional information concerning the records covered by a proposed schedule. These, too, may be requested and will be provided once the appraisal is completed. Requesters will be given 30 days to submit comments. ADDRESSES: You may request a copy of any records schedule identified in this notice by contacting the Life Cycle Management Division (NWML) using one of the following means: Mail: NARA (NWML), 8601 Adelphi Road, College Park, MD 20740–6001 E-mail: requestschedule@nara.gov. FAX: 301–837–3698. Requesters must cite the control number, which appears in parentheses after the name of the agency which submitted the schedule, and must provide a mailing address. Those who desire appraisal reports should so indicate in their request. FOR FURTHER INFORMATION CONTACT: Laurence Brewer, Director, Life Cycle Management Division (NWML), National Archives and Records Administration, 8601 Adelphi Road, College Park, MD 20740–6001. Telephone: 301–837–1539. E-mail: records.mgt@nara.gov. SUPPLEMENTARY INFORMATION: Each year Federal agencies create billions of records on paper, film, magnetic tape, and other media. To control this accumulation, agency records managers prepare schedules proposing retention periods for records and submit these schedules for NARA’s approval, using the Standard Form (SF) 115, Request for Records Disposition Authority. These schedules provide for the timely transfer into the National Archives of historically valuable records and authorize the disposal of all other records after the agency no longer needs them to conduct its business. Some schedules are comprehensive and cover all the records of an agency or one of its major subdivisions. Most schedules, however, cover records of only one office or program or a few series of records. Many of these update previously approved schedules, and some include records proposed as permanent. The schedules listed in this notice are media neutral unless specified otherwise. An item in a schedule is media neutral when the disposition instructions may be applied to records regardless of the medium in which the records are created and maintained. DATES: PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 30419 Items included in schedules submitted to NARA on or after December 17, 2007, are media neutral unless the item is limited to a specific medium. (See 36 CFR 1228.24(b)(3).) No Federal records are authorized for destruction without the approval of the Archivist of the United States. This approval is granted only after a thorough consideration of their administrative use by the agency of origin, the rights of the Government and of private persons directly affected by the Government’s activities, and whether or not they have historical or other value. Besides identifying the Federal agencies and any subdivisions requesting disposition authority, this public notice lists the organizational unit(s) accumulating the records or indicates agency-wide applicability in the case of schedules that cover records that may be accumulated throughout an agency. This notice provides the control number assigned to each schedule, the total number of schedule items, and the number of temporary items (the records proposed for destruction). It also includes a brief description of the temporary records. The records schedule itself contains a full description of the records at the file unit level as well as their disposition. If NARA staff has prepared an appraisal memorandum for the schedule, it too includes information about the records. Further information about the disposition process is available on request. Schedules Pending 1. Department of Agriculture, Food Safety and Inspection Service (N1–462– 07–1, 1 item, 1 temporary item). Master file associated with an electronic information system used to analyze food inspection performance data. The proposed disposition instructions are limited to electronic records. 2. Department of Homeland Security, Office of Public Affairs (N1–563–07–17, 13 items, 8 temporary items). Nonexecutive level biographies; routine photographs; agreements for nongovernmental, entertainment-oriented projects requesting use of the agency seal, insignia, and other assistance; and working papers and background materials. Proposed for permanent retention are executive level biographies, communication plans, mission-related photographs, press conference records, and press releases. 3. Department of Homeland Security, United States Citizenship and Immigration Services (N1–566–08–12, 2 items, 2 temporary items). Inputs and master file associated with a local area E:\FR\FM\27MYN1.SGM 27MYN1

Agencies

[Federal Register Volume 73, Number 102 (Tuesday, May 27, 2008)]
[Notices]
[Pages 30418-30419]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-11633]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 21, 2007, AMRI 
Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144, made 
application by renewal to the Drug Enforcement Administration (DEA) as 
a bulk manufacturer of the basic classes of controlled substances 
listed in schedules I and II:

------------------------------------------------------------------------
                   Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)..........................                             I
Tetrahydrocannabinols (7370)..............                             I
Amphetamine (1100)........................                            II
Lisdexamfetamine (1205)...................                            II
Methylphenidate (1724)....................                            II
Pentobarbital (2270)......................                            II
Hydrocodone (9193)........................                            II
Meperidine (9230).........................                            II
Dextropropoxyphene, bulk (non-dosage form)                            II
 (9273)...................................
Oxymorphone (9652)........................                            II
Fentanyl (9801)...........................                            II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for use 
in product development and for distribution to its customers. In 
reference to drug code 7360 (Marihuana), the company plans to bulk 
manufacture cannabidiol as a synthetic intermediate. This controlled 
substance will be further synthesized to bulk

[[Page 30419]]

manufacture a synthetic THC (7370). No other activity for this drug 
code is authorized for this registration.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than July 28, 2008.

    Dated: May 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-11633 Filed 5-23-08; 8:45 am]
BILLING CODE 4410-09-P